| scholarly article | Q13442814 |
| P356 | DOI | 10.7164/ANTIBIOTICS.44.172 |
| P953 | full work available at URL | https://www.jstage.jst.go.jp/article/antibiotics1968/44/2/44_2_172/_pdf |
| P698 | PubMed publication ID | 1826288 |
| P7228 | access restriction status | open access | Q232932 |
| P2093 | author name string | H. W. Lahm | |
| A. M. Labhardt | |||
| A. M. LABHARDT | |||
| D. F. Wyss | |||
| D. F. WYSS | |||
| H.-W. LAHM | |||
| M. Manneberg | |||
| M. MANNEBERG | |||
| P2860 | cites work | Improved spectral resolution in cosy 1H NMR spectra of proteins via double quantum filtering | Q29618846 |
| Anantin--a peptide antagonist of the atrial natriuretic factor (ANF). I. Producing organism, fermentation, isolation and biological activity | Q67914725 | ||
| Separation of amino acid enantiomers and chiral amines using precolumn derivatization with (+)-1-(9-fluorenyl)ethyl chloroformate and reversed-phase liquid chromatography | Q69049139 | ||
| Systematic application of high-resolution, phase-sensitive two-dimensional 1H-NMR techniques for the identification of the amino-acid-proton spin systems in proteins. Rabbit metallothionein-2 | Q70096375 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacology | Q128406 |
| Streptomyces coerulescens | Q22287120 | ||
| N(1)Gly-DL-Phe-DL-xiIle-Gly-DL-Trp-Gly-DL-Asn-DL-Asp(1)-DL-xiIle-DL-Phe-Gly-DL-Ala(imidazol-2-yl)-DL-Tyr-DL-Ser-Gly-DL-Asp-DL-Phe-OH | Q105109967 | ||
| N(1)Gly-Phe-D-aIle-Gly-D-Trp-Gly-D-Asn-Asp(1)-aIle-Phe-Gly-His-Tyr-Ser-Gly-D-Asp-D-Phe-OH | Q105216259 | ||
| P6954 | online access status | open access | Q232932 |
| P304 | page(s) | 172-180 | |
| P577 | publication date | 1991-02-01 | |
| 2012-03-01 | |||
| P1433 | published in | The Journal of Antibiotics | Q7743552 |
| P1476 | title | Anantin--a peptide antagonist of the atrial natriuretic factor (ANF). II. Determination of the primary sequence by NMR on the basis of proton assignments | |
| Anantin-A peptide antagonist of the atrial natriuretic factor(ANF). II. Determination of the primary sequence by NMR on the basis of proton assignments | |||
| P478 | volume | 44 |
| Q72156376 | A fluorescence study of tryptophan-histidine interactions in the peptide anantin and in solution |
| Q67914725 | Anantin--a peptide antagonist of the atrial natriuretic factor (ANF). I. Producing organism, fermentation, isolation and biological activity |
| Q57025734 | Biosynthetic Gene Cluster of a d-Tryptophan-Containing Lasso Peptide, MS-271 |
| Q93551715 | Catalytic Receptors |
| Q27683559 | Caulosegnins I-III: a highly diverse group of lasso peptides derived from a single biosynthetic gene cluster |
| Q113850368 | Diversity of the bacteriocins, their classification and potential applications in combat of antibiotic resistant and clinically relevant pathogens |
| Q42453221 | Functional and pharmacological characterization of the natriuretic peptide-dependent lipolytic pathway in human fat cells |
| Q48101928 | General rules of fragmentation evidencing lasso structures in CID and ETD. |
| Q92533436 | Genome mining for lasso peptides: past, present, and future |
| Q42560071 | Guide to Receptors and Channels (GRAC), 2nd edition (2007 Revision). |
| Q56639335 | Guide to Receptors and Channels (GRAC), 4th Edition |
| Q34228968 | Guide to Receptors and Channels (GRAC), 5th edition |
| Q43054584 | Guide to receptors and channels, 2nd edition |
| Q27663631 | High‐Resolution Crystal Structure of a Lasso Peptide |
| Q97683962 | How to harness biosynthetic gene clusters of lasso peptides |
| Q88175897 | Identification of Lasso Peptide Topologies Using Native Nanoelectrospray Ionization-Trapped Ion Mobility Spectrometry-Mass Spectrometry |
| Q91775876 | Inhibition of natriuretic peptide receptor 1 reduces itch in mice |
| Q92252615 | Interventions in the B-type natriuretic peptide signalling pathway as a means of controlling chronic itch |
| Q38877084 | In vitro and in vivo assessment of heart-homing porous silicon nanoparticles |
| Q45773079 | Isolation and structural characterization of capistruin, a lasso peptide predicted from the genome sequence of Burkholderia thailandensis E264. |
| Q101053903 | Lasso Peptides: Heterologous Production and Potential Medical Application |
| Q38807411 | Lasso peptide, a highly stable structure and designable multifunctional backbone |
| Q46224005 | Lasso peptides from proteobacteria: Genome mining employing heterologous expression and mass spectrometry |
| Q36915481 | Low-molecular-weight post-translationally modified microcins. |
| Q71213252 | MS-271, a novel inhibitor of calmodulin-activated myosin light chain kinase from Streptomyces sp.--I. Isolation, structural determination and biological properties of MS-271 |
| Q71213257 | MS-271, a novel inhibitor of calmodulin-activated myosin light chain kinase from Streptomyces sp.--II. Solution structure of MS-271: characteristic features of the "lasso' structure |
| Q27642307 | Microcin J25 has a threaded sidechain-to-backbone ring structure and not a head-to-tail cyclized backbone |
| Q30842900 | Microcin J25, from the macrocyclic to the lasso structure: implications for biosynthetic, evolutionary and biotechnological perspectives |
| Q34184014 | Molecular cloning of the gene cluster for lariatin biosynthesis of Rhodococcus jostii K01-B0171. |
| Q37978834 | NMR as an effective tool for the structure determination of lasso peptides |
| Q29028296 | Natriuretic peptide |
| Q93498301 | Natriuretic peptide |
| Q54483068 | Natriuretic peptide receptors and heart failure: to B or not to B blocked? |
| Q36135917 | Neuronal regulation and function of natriuretic peptide receptor C. |
| Q40731273 | Novel bioactive compounds from Actinomycetes: a short review (1988-1992). |
| Q50916072 | Novel propeptin analog, propeptin-2, missing two amino acid residues from the propeptin C-terminus loses antibiotic potency. |
| Q41685247 | Novel screen methodologies for identification of new microbial metabolites with pharmacological activity |
| Q27672155 | Precursor-centric genome-mining approach for lasso peptide discovery |
| Q104884527 | Propeptin, a New Inhibitor of Prolyl Endopeptidase Produced by Microbispora. I. Fermentation, Isolation and Biological Properties. |
| Q43996027 | Propeptin, a new inhibitor of prolyl endopeptidase produced by microbispora II. Determination of chemical structure |
| Q34378955 | Prospecting genomes for lasso peptides |
| Q72403042 | RES-701-1, a novel and selective endothelin type B receptor antagonist produced by Streptomyces sp. RE-701. II. Determination of the primary sequence |
| Q70889788 | RES-701-2, a novel and selective endothelin type B receptor antagonist produced by Streptomyces sp. II. Determination of the primary structure |
| Q37566506 | Ribosomal peptide natural products: bridging the ribosomal and nonribosomal worlds |
| Q34312732 | Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature |
| Q36182562 | Signatures of Mechanically Interlocked Topology of Lasso Peptides by Ion Mobility-Mass Spectrometry: Lessons from a Collection of Representatives. |
| Q52871250 | Site-directed and global incorporation of orthogonal and isostructural noncanonical amino acids into the ribosomal lasso peptide capistruin. |
| Q39153786 | Sungsanpin, a lasso peptide from a deep-sea streptomycete |
| Q30486741 | The Concise Guide to PHARMACOLOGY 2013/14: catalytic receptors |
| Q27684439 | The astexin-1 lasso peptides: biosynthesis, stability, and structural studies |
| Q38415092 | Transmission of pruriceptive signals |
| Q33291917 | Two enzymes catalyze the maturation of a lasso peptide in Escherichia coli |
| Q80682803 | Tying the knot: making of lasso peptides |
| Q57212787 | Ulleungdin, a Lasso Peptide with Cancer Cell Migration Inhibitory Activity Discovered by the Genome Mining Approach |
| Q35048835 | Urinary responses to acute moxonidine are inhibited by natriuretic peptide receptor antagonist |
| Q27688948 | Xanthomonins I-III: a new class of lasso peptides with a seven-residue macrolactam ring |
Search more.